Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

iSpecimen Inc. (ISPC) vs T2 Biosystems, Inc. (TTOO)

iSpecimen Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $3.1M — 2.1× the size. T2 Biosystems, Inc. grew revenue faster over the last twelve months: −30.2% against −92.1%. T2 Biosystems, Inc. has the higher net margin (−559.5% vs −2,449.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, T2 Biosystems, Inc. leads on 12 and iSpecimen Inc. on 2.

Valuation

Metric ISPC TTOO Diagnostics & Research median
P/E n/m n/m 33.95
P/S 3.77 n/m 4.87
P/B 1.01 n/m 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA 0.31 n/m 25.20
EV/Sales (5.55) 0.64 5.66
Earnings yield (4,479.37%) 0.00% (1.75%)
Free cash flow yield (617.94%) 0.00% (0.13%)

Profitability

Metric ISPC TTOO Diagnostics & Research median
Gross margin (108.26%) (76.76%) 50.89%
Operating margin (2,020.05%) (542.59%) (8.57%)
Net margin (2,449.02%) (559.52%) (6.37%)
Free cash flow margin (1,866.61%) (476.64%) 0.00%
Return on equity (968.44%) 277.61% (2.92%)
Return on assets (170.09%) (140.00%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ISPC TTOO Diagnostics & Research median
Revenue growth (TTM) (92.11%) (30.19%) 7.69%
EPS growth (last fiscal year) 87.03% 98.44% —
Revenue growth, 5-year CAGR (25.10%) (7.29%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ISPC TTOO Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 0.82 0.40 2.02
Net debt to EBITDA 0.95 0.32 0.78

Dividend

Metric ISPC TTOO Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ISPC TTOO Diagnostics & Research median
Market cap 3.12m 6.48m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack